Market Tracker

06/21 5:15pm ET

Mesoblast Ltd (NASDAQ:MESO)

6.06
Delayed Data
As of Jun 21
 +0.52 / +9.39%
Today’s Change
4.74
Today|||52-Week Range
8.55
+3.77%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.54
Today’s open6.44
Day’s range5.89 - 6.66
Volume284,414
Average volume (3 months)58,580
Market cap$518.9M
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+53.03%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales322.85
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.05+0.26%
RTIXRTI Surgical Inc-0.10-2.08%
SIENSientra Inc-0.61-3.06%
OFIXOrthofix Internation...-0.87-1.43%
Data as of 4:01pm ET, 06/21/2018

Financials

Next reporting dateAugust 28, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Joshua Muntner
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts